Brainstorm Cell Therapeutics(DE:GHD)
€2.690.00 (0.00%)
DE:GHD
Brainstorm Cell Therapeutics earnings date
€2.69
At close:0.00 (0.00%)
Brainstorm Cell Therapeutics (GHD) Q2 2023 Earnings Report
1 Followers
DE:GHD Q2 2023 EPS Results
- Actual EPS
- -EUR 1.77
- Consensus EPS
- -EUR 1.97
- Beat/Miss
- Beat by +EUR 0.20
- One Year Ago EPS
- -EUR 2.59
DE:GHD Q2 2023 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/14/2023
- Time
- Before Open
- Conference Call
- Monday, August 14, 2023
DE:GHD Upcoming Earnings
Brainstorm Cell Therapeutics's next earnings date is estimated for November 16, 2026, based on past reporting schedules.
Q2 2023 Earnings Call Audio
DE:GHD Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:GHD Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 16, 2026 | 2026 (Q3) | -0.16- | -0.17 | ― | ― |
| Aug 14, 2026 | 2026 (Q2) | ―-0.32 | -0.31 | -2.94% (-0.01) | |
| May 15, 2026 | 2026 (Q1) | ―-0.17 | -0.41 | 57.78% (+0.24) | |
| Mar 31, 2026 | 2025 (Q4) | -0.25-0.17 | -0.41 | 57.78% (+0.24) | |
| Nov 14, 2025 | 2025 (Q3) | -0.34-0.17 | -0.46 | 62.75% (+0.29) | |
| Aug 14, 2025 | 2025 (Q2) | -0.34-0.31 | 0.54 | -156.67% (-0.85) | |
| May 16, 2025 | 2025 (Q1) | ―-0.41 | -0.68 | 40.00% (+0.27) | |
| Mar 31, 2025 | 2024 (Q4) | -0.88-0.41 | -0.68 | 40.00% (+0.27) | |
| Nov 14, 2024 | 2024 (Q3) | -0.52-0.46 | -0.41 | -13.33% (-0.05) | |
| Aug 14, 2024 | 2024 (Q2) | -0.480.54 | -1.77 | 130.77% (+2.31) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
